Results 1 to 10 of about 1,846 (126)

Emerging agents for boron neutron capture therapy: Biomolecular carriers paving the way for precision radiotherapy. [PDF]

open access: yesPrecis Radiat Oncol
Boron neutron capture therapy (BNCT) requires key non‐negotiable technical criteria: megadose administration, precise tumor‐specific targeting, favorable biocompatibility, and sustained tumor retention. Overcoming these interconnected challenges fundamentally depends on biomolecular carriers, which are critical for translating the therapeutic potential
Chen C   +6 more
europepmc   +2 more sources

Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma [PDF]

open access: yesInternational Journal of Molecular Sciences, 2023
Peir Jinn-Jer, Yi Yen Lee, Tien-Li Lan
exaly   +2 more sources

Amino Acid-Based Boron Carriers in Boron Neutron Capture Therapy (BNCT) [PDF]

open access: yesPharmaceutics, 2023
Juri Timonen   +2 more
exaly   +2 more sources

Core clinical procedures and efficacy-enhancing strategies in boron neutron capture therapy [PDF]

open access: yesDiscover Oncology
Boron Neutron Capture Therapy (BNCT) is a binary targeted radiotherapy modality based on nuclear capture reactions. This technique exploits the tumor-targeting capability of boron compounds and their high thermal neutron capture cross-section, inducing ...
Qinqin Ma   +8 more
doaj   +2 more sources

Boron-10 carriers and their applications in boron neutron capture therapy. [PDF]

open access: yesPrecis Radiat Oncol
Summary of different types of boron drugs. Abstract Boron neutron capture therapy (BNCT) has emerged as a promising therapeutic modality in cancer treatment, demonstrating the ability to selectively eliminate cancer cells through the 10B(n,α)7Li nuclear reaction with minimal side effects on normal tissues.
Tang D   +7 more
europepmc   +2 more sources

Chordoma Treatment with Boron Neutron Capture Therapy (BNCT): Experimental Insights

open access: yesProceedings
Boron Neutron Capture Therapy (BNCT) is a particle beam therapy that enables the precise targeting of tumors at the cellular level [...]
Yoshiki Fujikawa   +9 more
doaj   +3 more sources

Systemic Immunity Triggered by Boron Neutron Capture Therapy via Manganese-Borate Complex [PDF]

open access: yesMaterials Today Bio
Conventional radiotherapy compromises antitumor immunity through collateral damage to immune cells. While boron neutron capture therapy (BNCT) enables tumor-selective 10B (n, α) 7Li reactions, clinical agents like boronophenylalanine (BPA) suffer from ...
Chang Chen   +19 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy